IGF1 and metabolic syndrome: The proposed pathophysiological links between MetS and carcinogenesis include chronic systemic inflammation, increased oxidative stress, insulin resistance, hyperinsulinemia, and the dysregulation of growth-promoting pathways such as the insulin-like growth factor-1 (IGF-1) axis.